NCT00003737View on ClinicalTrials.gov

Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Neuroblastoma
Interventions
DRUG

becatecarin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003737 - Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma | Biotech Hunter | Biotech Hunter